Incontinence Devices - Medical Devices Pipeline Assessment, 2017

Published : Sep-2017

No. of Pages : 336

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 14
2 Introduction 15
2.1 Incontinence Devices Overview 15
3 Products under Development 16
3.1 Incontinence Devices - Pipeline Products by Stage of Development 16
3.2 Incontinence Devices - Pipeline Products by Segment 17
3.3 Incontinence Devices - Pipeline Products by Territory 18
3.4 Incontinence Devices - Pipeline Products by Regulatory Path 19
3.5 Incontinence Devices - Pipeline Products by Estimated Approval Date 20
3.6 Incontinence Devices - Ongoing Clinical Trials 21
4 Incontinence Devices - Pipeline Products under Development by Companies 22
4.1 Incontinence Devices Companies - Pipeline Products by Stage of Development 22
4.2 Incontinence Devices - Pipeline Products by Stage of Development 25
5 Incontinence Devices Companies and Product Overview 28
5.1 Applied Catheter Technologies Inc. Company Overview 28
5.2 Atlantic Therapeutics Group Ltd Company Overview 29
5.3 AugmentRx Medical Inc. Company Overview 30
5.4 Biocrede Inc Company Overview 31
5.5 BioModics ApS Company Overview 32
5.6 Bioring SA (Inactive) Company Overview 33
5.7 Boston Scientific Corp Company Overview 34
5.8 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 38
5.9 Coloplast A/S Company Overview 39
5.10 Continara Limited (Inactive) Company Overview 41
5.11 Continental Dry-Works Company Overview 42
5.12 Control Flo Medical LLC Company Overview 43
5.13 ConvaTec Inc. Company Overview 44
5.14 DUALIS MedTech GmbH Company Overview 45
5.15 Ecole Polytechnique de Montreal Company Overview 46
5.16 Elecro Chem, Inc. Company Overview 47
5.17 Elidah, LLC Company Overview 48
5.18 EMKinetics, Inc. Company Overview 49
5.19 Endo International Plc Company Overview 50
5.20 EndoStim Inc Company Overview 53
5.21 Enox Biopharma Inc Company Overview 54
5.22 Ergoresearch Ltd Company Overview 55
5.23 Ethicon US LLC Company Overview 56
5.24 Facet Technologies LLC Company Overview 57
5.25 Flat Medical Company Overview 58
5.26 FLEXIPROBE LTD. Company Overview 60
5.27 Floelle Inc. Company Overview 61
5.28 FocusStart LLC Company Overview 62
5.29 Forconti Medical Ltd. Company Overview 63
5.30 GR Dome Medical Ltd. Company Overview 66
5.31 GT Urological, LLC Company Overview 68
5.32 Hill-Rom Holdings Inc Company Overview 70
5.33 Hollister Incorporated Company Overview 71
5.34 Invent Medic Sweden AB Company Overview 72
5.35 Kleeven International BV Company Overview 75
5.36 Leto Medical, LLC Company Overview 76
5.37 Lilium Otsuka Co., Ltd. Company Overview 77
5.38 Marvao Medical Devices Limited Company Overview 78
5.39 Medici Medical Srl Company Overview 79
5.40 Medi-Globe GmbH Company Overview 80
5.41 Medprin Regenerative Medical Technologies Co Ltd Company Overview 81
5.42 Minnesota Medical Technologies Corporation Company Overview 82
5.43 MyoPowers Medical Technologies France SAS Company Overview 83
5.44 Nagasaki University Company Overview 84
5.45 NexHand Company Overview 85
5.46 Olympus Medical Systems Corp Company Overview 86
5.47 PetVivo Holdings Inc Company Overview 87
5.48 Polytechnic University of Catalonia Company Overview 88
5.49 Precision Medical Devices, Inc. Company Overview 89
5.50 Prosurg Inc Company Overview 91
5.51 Proxy Biomedical Ltd Company Overview 92
5.52 Quick-Med Technologies, Inc. Company Overview 93
5.53 Rambam Health Care Campus Company Overview 94
5.54 Salusion B.V. Company Overview 95
5.55 Sharklet Technologies, Inc. Company Overview 96
5.56 Solace Therapeutics Inc Company Overview 97
5.57 Stanford University Company Overview 100
5.58 Suneva Medical Inc Company Overview 101
5.59 Tengion Inc Company Overview 102
5.60 The Feinstein Institute for Medical Research Company Overview 103
5.61 University of Basel Company Overview 105
5.62 University of California San Diego Company Overview 106
5.63 University of Michigan Pediatric Device Consortium Company Overview 107
5.64 University of Nottingham Company Overview 108
5.65 University of Saskatchewan Company Overview 109
5.66 University of Utah Company Overview 110
5.67 Urinary BioSolutions LLC (Inactive) Company Overview 112
5.68 Uromedica Inc Company Overview 113
5.69 UroMems SAS Company Overview 116
5.70 Urova Medical Inc. Company Overview 117
5.71 Urovalve, Inc. Company Overview 118
5.72 Verathon Inc Company Overview 120
5.73 Vesiflo, Inc. Company Overview 123
5.74 Vysera Biomedical Ltd Company Overview 124
5.75 Washington University in St Louis Company Overview 125
5.76 Watkins Conti Products Inc Company Overview 126
5.77 Xennovate Medical LLC Company Overview 129
6 Incontinence Devices- Recent Developments 131
6.1 Aug 31, 2017: The Cooper Companies Announces Third Quarter 2017 Results 131
6.2 Aug 30, 2017: Medline Remains Operational Through Hurricane Harvey and Current Recovery 131
6.3 Aug 29, 2017: Gilles Laporte elected on the Board of Directors of Ergoresearch 132
6.4 Aug 28, 2017: Bactiguard Appoints New CFO 132
6.5 Aug 23, 2017: Henry Ford Hospital CEO Announces Retirement 133
6.6 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 133
6.7 Aug 21, 2017: Covalon Releases Third Quarter Financial Results 136
6.8 Aug 16, 2017: Kane Biotech - Q2 2017 Financial Results 137
6.9 Aug 16, 2017: Coloplast delivers satisfactory Q3 result 137
6.10 Aug 14, 2017: ConvaTec appoints two Non-Executive Directors 138
6.11 Aug 14, 2017: Zynex Announces 2017 Second Quarter Earnings 139
6.12 Aug 10, 2017: Bactiguard Holding: Interim report for Q2 2017 140
6.13 Aug 10, 2017: Invo Bioscience Reports Record Second Quarter 2017 Financial Results 142
6.14 Aug 09, 2017: HARTMANN GROUP is investing in the future 143
6.15 Aug 09, 2017: Dentsply Sirona Reports Second Quarter 2017 Results 144
6.16 Aug 09, 2017: Sientra Reports Second Quarter 2017 Financial Results 146
6.17 Aug 08, 2017: Endo Reports Second-Quarter 2017 Financial Results 147
6.18 Aug 03, 2017: ConvaTec Group: Board Changes 149
6.19 Aug 03, 2017: ConvaTec Group First Half 2017 Results 150
6.20 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results 151
6.21 Aug 01, 2017: Owens & Minor Reports 2nd Quarter 2017 Financial Results 153
6.22 Jul 31, 2017: Sanofi Raises FY 2017 Business EPS Guidance to Broadly Stable at CER 154
6.23 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 161
6.24 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 162
6.25 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 162
6.26 Jul 21, 2017: Endo to Restructure Manufacturing Network 164
6.27 Jul 20, 2017: Atlantic Therapeutics Announce Partnership with Female Pelvic Health Specialists June Medical 165
6.28 Jul 19, 2017: Merz To Consolidate Operations in Racine County, Create Up To 20 Jobs 165
6.29 Jul 12, 2017: Sanofi: Pre-quarterly Results Communication 165
6.30 Jul 11, 2017: Uromedica Announces Launch of ProACT Adjustable Continence Therapy for Men with FDA Approval and Reimbursement Coding 167
6.31 Jul 08, 2017: Class Action Regarding Boston Scientific Transvaginal Mesh Devices Has Been Certified 168
7 Appendix 332
7.1 Methodology 332
7.2 About GlobalData 335
7.3 Contact Us 335
7.4 Disclaimer 335

1.1 List of Tables
Table 1: Incontinence Devices - Pipeline Products by Stage of Development 17
Table 2: Incontinence Devices - Pipeline Products by Segment 18
Table 3: Incontinence Devices - Pipeline Products by Territory 19
Table 4: Incontinence Devices - Pipeline Products by Regulatory Path 20
Table 5: Incontinence Devices - Pipeline Products by Estimated Approval Date 21
Table 6: Incontinence Devices - Ongoing Clinical Trials 22
Table 7: Incontinence Devices Companies - Pipeline Products by Stage of Development 23
Table 8: Incontinence Devices - Pipeline Products by Stage of Development 26
Table 9: Applied Catheter Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
Table 10: Drug Coated Catheter - Product Status 29
Table 11: Drug Coated Catheter - Product Description 29
Table 12: Atlantic Therapeutics Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
Table 13: INNOVO - Product Status 30
Table 14: INNOVO - Product Description 30
Table 15: AugmentRx Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
Table 16: SOLVE - Product Status 31
Table 17: SOLVE - Product Description 31
Table 18: Biocrede Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 19: Urinary Catheter - Product Status 32
Table 20: Urinary Catheter - Product Description 32
Table 21: BioModics ApS Pipeline Products & Ongoing Clinical Trials Overview 33
Table 22: Indwelling Urinary Catheter - Product Status 33
Table 23: Indwelling Urinary Catheter - Product Description 33
Table 24: Bioring SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 34
Table 25: Biowing - Product Status 34
Table 26: Biowing - Product Description 34
Table 27: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 35
Table 28: Next Generation Sling System - Product Status 35
Table 29: Next Generation Sling System - Product Description 35
Table 30: Pathfinder RP - Product Status 36
Table 31: Pathfinder RP - Product Description 36
Table 32: Pathfinder TOT - Product Status 36
Table 33: Pathfinder TOT - Product Description 37
Table 34: SIS Sling System - Product Status 37
Table 35: SIS Sling System - Product Description 37
Table 36: Solyx I Sling System - Product Status 38
Table 37: Solyx I Sling System - Product Description 38
Table 38: Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 39
Table 39: Cerashield Coated Silicone Urinary Catheter - Product Status 39
Table 40: Cerashield Coated Silicone Urinary Catheter - Product Description 39
Table 41: Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview 40
Table 42: SpeediCath Compact Eve CH10 - Product Status 40
Table 43: SpeediCath Compact Eve CH10 - Product Description 40
Table 44: SpeediCath Compact Eve CH14 - Product Status 41
Table 45: SpeediCath Compact Eve CH14 - Product Description 41
Table 46: Continara Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 42
Table 47: UTROL Bionic Sphincter - Product Status 42
Table 48: UTROL Bionic Sphincter - Product Description 42
Table 49: Continental Dry-Works Pipeline Products & Ongoing Clinical Trials Overview 43
Table 50: The Pocket - Product Status 43
Table 51: The Pocket - Product Description 43
Table 52: Control Flo Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 44
Table 53: ResQ Urological Catheter System - Product Status 44
Table 54: ResQ Urological Catheter System - Product Description 44
Table 55: ConvaTec Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
Table 56: GentleCath Glide Intermittent Catheter - Product Status 45
Table 57: GentleCath Glide Intermittent Catheter - Product Description 45
Table 58: DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 46
Table 59: Implantable Wireless Sphincter System - Product Status 46
Table 60: Implantable Wireless Sphincter System - Product Description 46
Table 61: Ecole Polytechnique de Montreal Pipeline Products & Ongoing Clinical Trials Overview 47
Table 62: Bladder Implant - Product Status 47
Table 63: Bladder Implant - Product Description 47
Table 64: Elecro Chem, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
Table 65: TVS 2 - Product Status 48
Table 66: TVS 2 - Product Description 48
Table 67: Elidah, LLC Pipeline Products & Ongoing Clinical Trials Overview 49
Table 68: Elitone - Product Status 49
Table 69: Elitone - Product Description 49
Table 70: EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
Table 71: TranStim Transdermal Neuromodulation System - Product Status 50
Table 72: TranStim Transdermal Neuromodulation System - Product Description 50
Table 73: Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview 51
Table 74: CONTINUUM Device - Product Status 51
Table 75: CONTINUUM Device - Product Description 51
Table 76: TOPAS Sling System - Product Status 52
Table 77: TOPAS Sling System - Product Description 52
Table 78: UroVive Self-Contained Micro-Balloon System - Product Status 52
Table 79: UroVive Self-Contained Micro-Balloon System - Product Description 53
Table 80: EndoStim Inc Pipeline Products & Ongoing Clinical Trials Overview 54
Table 81: Implantable Device - Urinary Incontinence - Product Status 54
Table 82: Implantable Device - Urinary Incontinence - Product Description 54
Table 83: Enox Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview 55
Table 84: Self-Sterilizing Urinary Catheter - Product Status 55
Table 85: Self-Sterilizing Urinary Catheter - Product Description 55
Table 86: Ergoresearch Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
Table 87: Urinary Disorders Implant - Product Status 56
Table 88: Urinary Disorders Implant - Product Description 56
Table 89: Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 57
Table 90: GYNECARE SUI Sling Next Generation - Product Status 57
Table 91: GYNECARE SUI Sling Next Generation - Product Description 57
Table 92: Facet Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 58
Table 93: Periurethral Device - Product Status 58
Table 94: Periurethral Device - Product Description 58
Table 95: Flat Medical Pipeline Products & Ongoing Clinical Trials Overview 59
Table 96: UroAid - F - Product Status 59
Table 97: UroAid - F - Product Description 59
Table 98: UroAid - IV - Product Status 60
Table 99: UroAid - IV - Product Description 60
Table 100: FLEXIPROBE LTD. Pipeline Products & Ongoing Clinical Trials Overview 61
Table 101: Flexiprobe Device - Product Status 61
Table 102: Flexiprobe Device - Product Description 61
Table 103: Floelle Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
Table 104: Floelle Device - Product Status 62
Table 105: Floelle Device - Product Description 62
Table 106: FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 63
Table 107: Anti-biofilm Urological Catheter - Product Status 63
Table 108: Anti-biofilm Urological Catheter - Product Description 63
Table 109: Forconti Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 64
Table 110: ForConti Fecal Management System - Product Status 64
Table 111: ForConti Fecal Management System - Product Description 64
Table 112: Forconti Medical Ltd. - Ongoing Clinical Trials Overview 65
Table 113: ForConti Fecal Management System - Safety and Effectiveness Evaluation of the ForConti Fecal Management System - Pilot Study 66
Table 114: GR Dome Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
Table 115: UriCap-F - Product Status 67
Table 116: UriCap-F - Product Description 67
Table 117: UriTop-F - Product Status 68
Table 118: UriTop-F - Product Description 68
Table 119: GT Urological, LLC Pipeline Products & Ongoing Clinical Trials Overview 69
Table 120: Fecal Incontinence Device - Product Status 69
Table 121: Fecal Incontinence Device - Product Description 69
Table 122: Implantable Incontinence Device - Women - Product Status 70
Table 123: Implantable Incontinence Device - Women - Product Description 70
Table 124: Hill-Rom Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 71
Table 125: WatchCare Incontinence Management Device - Product Status 71
Table 126: WatchCare Incontinence Management Device - Product Description 71
Table 127: Hollister Incorporated Pipeline Products & Ongoing Clinical Trials Overview 72
Table 128: VaPro Touch Free Male Hydrophilic Intermittent Catheter - Product Status 72
Table 129: VaPro Touch Free Male Hydrophilic Intermittent Catheter - Product Description 72
Table 130: Invent Medic Sweden AB Pipeline Products & Ongoing Clinical Trials Overview 73
Table 131: TVS - Product Status 73
Table 132: TVS - Product Description 73
Table 133: Invent Medic Sweden AB - Ongoing Clinical Trials Overview 74
Table 134: TVS - An Open Randomized Controlled Multicenter Clinical Investigation with an Intra-vaginal Device for Stress Urinary Incontinence in Comparison to using Standard of Care 75
Table 135: Kleeven International BV Pipeline Products & Ongoing Clinical Trials Overview 76
Table 136: MAXAM Pelvic Floor Device - Product Status 76
Table 137: MAXAM Pelvic Floor Device - Product Description 76
Table 138: Leto Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 77
Table 139: Continent Ostomy System - Product Status 77
Table 140: Continent Ostomy System - Product Description 77
Table 141: Lilium Otsuka Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 78
Table 142: Next Gen Yuririn USH-052 Scanner - Product Status 78
Table 143: Next Gen Yuririn USH-052 Scanner - Product Description 78
Table 144: Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 79
Table 145: NexSite Drainage Catheter - Product Status 79
Table 146: NexSite Drainage Catheter - Product Description 79
Table 147: Medici Medical Srl Pipeline Products & Ongoing Clinical Trials Overview 80
Table 148: Time-Delayed Valve System - Product Status 80
Table 149: Time-Delayed Valve System - Product Description 80
Table 150: Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview 81
Table 151: Incontinence Prosthesis - Product Status 81
Table 152: Incontinence Prosthesis - Product Description 81
Table 153: Medprin Regenerative Medical Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 82
Table 154: Regen Sling - Product Status 82
Table 155: Regen Sling - Product Description 82
Table 156: Minnesota Medical Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 83
Table 157: myMiracle - Product Status 83
Table 158: myMiracle - Product Description 83
Table 159: MyoPowers Medical Technologies France SAS Pipeline Products & Ongoing Clinical Trials Overview 84
Table 160: ARTUS - Product Status 84
Table 161: ARTUS - Product Description 84
Table 162: Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview 85
Table 163: Urination Management System - Product Status 85
Table 164: Urination Management System - Product Description 85

1.2 List of Figures
Figure 1: Incontinence Devices - Pipeline Products by Stage of Development 17
Figure 2: Incontinence Devices - Pipeline Products by Segment 18
Figure 3: Incontinence Devices - Pipeline Products by Territory 19
Figure 4: Incontinence Devices - Pipeline Products by Regulatory Path 20
Figure 5: Incontinence Devices - Pipeline Products by Estimated Approval Date 21
Figure 6: Incontinence Devices - Ongoing Clinical Trials 22

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Incontinence Devices - Medical Devices Pipeline Assessment, 2017

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027